Thus, IL-4 does not increase the in-vitro drug resistance of CLL cells exposed to umbelliprenin, in contrast to other drugs that induce apoptosis of CLL cells, such as fludarabine. Here, IL4 is linked to B-cell chronic lymphocytic leukemia.